...
Considering Comorbidities of Psoriasis as a Basis for Therapeutic Selections
September 24, 2021

  When we think of psoriasis, we often visualize the external manifestations of disease that we can see, such as erythema (redness), induration (thickness), and desquamation (scaling); however, psoriasis is more than cosmetic disfigurement or skin disease. It is a chronic, relapsing, immune deregulatory inflammatory skin and joint disease that has been shown to significantly

...
Sun Pharma and DPAF lead the effort in PA-directed research
May 6, 2020

Dr. Alan Mendelsohn, Associate VP of Medical Affairs at Sun Pharma, and DPAF Vice Chair Cynthia Trickett sit down with Dermcast.tv for a conversation about the importance of research in the Derm PA community. Sun Pharma has recently provided DPAF with generous grant funding specifically for innovative, timely PA-directed research. Watch for informative details about

...
SDPA Fall 2018 | Walking Tour of the 2018 Abstracts
November 3, 2018

The sun in Orlando is bright and the weather is clear and cooler on the third full day of SDPA’s 16th Annual Fall Dermatology Conference. This morning Dr. Mark Russell led a Walking Tour of the 2018 Abstracts. He walked with a group of SDPA members as they viewed the posters presented in the Tuscan

...
Summer 2018 | Live Blog | Product Theater | Innovations in Dermatology
June 29, 2018

The first product theater on day 2 of the SDPA Annual Summer Conference was presented by Dr. Neal Bhatia and featured the use of Onexton and Retin-A Micro for the treatment of acne. Acne vulgaris is an inflammatory pilosebaceous disease that affects greater than 80% adolescents, up to 12% women, and can persist after the